Although studies investigating the antigen specificity of tissue-infiltrating T cells during the acute infection are still scarce, SARS-CoV-2-specific CD4+ and CD8+ T cells have been found in the bone marrow, spleen, lymph nodes, lung, and nasal mucosa of COVID-19 patients up to 6 months after infection [117,118,119]. This evidence concerns the gene CD8A and infection.